{"id":326,"date":"2024-10-12T10:24:13","date_gmt":"2024-10-12T10:24:13","guid":{"rendered":"https:\/\/jadicell.therapeuticsolutionsint.com\/?page_id=326"},"modified":"2025-01-04T11:21:06","modified_gmt":"2025-01-04T11:21:06","slug":"home","status":"publish","type":"page","link":"https:\/\/jadicell.therapeuticsolutionsint.com\/","title":{"rendered":"Home"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Header&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;gcid-3cfc8c0c-5557-4a5d-9dab-24e78d615311&#8243; collapsed=&#8221;on&#8221; global_colors_info=&#8221;{%22gcid-3cfc8c0c-5557-4a5d-9dab-24e78d615311%22:%91%22background_color%22%93}&#8221;][et_pb_row _builder_version=&#8221;4.24.3&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;-38px|auto||auto||&#8221; custom_padding=&#8221;0px|||||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.3&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.24.3&#8243; _module_preset=&#8221;default&#8221; min_height=&#8221;573px&#8221; custom_margin=&#8221;-38px||-320px|||&#8221; custom_padding=&#8221;52px|||||&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<h4 style=\"text-align: center;\">Welcome to the licensing division of TSOI for the <strong>JadiCell\u2122<\/strong> Adult Donor Multi-Potent Mesenchymal Stem Cells.<\/h4>\n<p>The available uses of <strong>JadiCell\u2122<\/strong> for neurological and lung diseases are available for licensing under issued <span><a href=\"https:\/\/patents.google.com\/patent\/US9803176B2\/en\" target=\"_blank\" rel=\"noopener\">US Patent No.: 9,803,176 B2<\/a> and <a href=\"https:\/\/jadicell.therapeuticsolutionsint.com\/index.php\/jadicell-master-list\/\">multiple patent pending applications<\/a>.<br \/><\/span><\/p>\n<h3 id=\"title\" class=\"scroll-target style-scope patent-result\"><strong><span style=\"font-size: medium;\">Methods and compositions for the clinical derivation of an allogenic cell and therapeutic uses<\/span><\/strong><\/h3>\n<div class=\"horizontal layout style-scope patent-result\">\n<div class=\"flex-3 style-scope patent-result\" marginright=\"\">\n<section id=\"abstract\" class=\"style-scope patent-result\">\n<div class=\"flex style-scope patent-result\">Abstract<\/div>\n<div class=\"layout horizontal style-scope patent-text\">\n<section id=\"text\" class=\"flex style-scope patent-text\"><abstract mxw-id=\"PA208327660\" lang=\"EN\" load-source=\"patent-office\" class=\"style-scope patent-text\">\u00a0<\/p>\n<div id=\"p-0001\" num=\"0000\" class=\"abstract style-scope patent-text\">Various cells, stem cells, and stem cell components, including associated methods of generating and using such cells are provided. In another aspect, the isolated cell expresses at least eight cell markers selected from CD29, CD73, CD90, CD146, CD166, SSEA4, CD9, CD44, CD146, or CD105. In another aspect, the isolated cell does not express at least eight cell markers selected from CD45, CD34, CD14, CD79, CD106, CD86, CDS0, CD80, CD19, CD117, Stro-1, or HLA-DR and are negative for NANOG.<\/div>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/jadicell.therapeuticsolutionsint.com\/wp-content\/uploads\/2024\/10\/jadicell_panel-1024x345.png\" width=\"1024\" height=\"345\" alt=\"\" class=\"wp-image-62 alignnone size-large\" srcset=\"https:\/\/jadicell.therapeuticsolutionsint.com\/wp-content\/uploads\/2024\/10\/jadicell_panel-980x331.png 980w, https:\/\/jadicell.therapeuticsolutionsint.com\/wp-content\/uploads\/2024\/10\/jadicell_panel-480x162.png 480w\" sizes=\"auto, (min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1024px, 100vw\" \/><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><\/abstract><\/section>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Welcome to the licensing division of TSOI for the JadiCell\u2122 Adult Donor Multi-Potent Mesenchymal Stem Cells. The available uses of JadiCell\u2122 for neurological and lung diseases are available for licensing under issued US Patent No.: 9,803,176 B2 and multiple patent pending applications. Methods and compositions for the clinical derivation of an allogenic cell and therapeutic [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-326","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/jadicell.therapeuticsolutionsint.com\/index.php\/wp-json\/wp\/v2\/pages\/326","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jadicell.therapeuticsolutionsint.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/jadicell.therapeuticsolutionsint.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/jadicell.therapeuticsolutionsint.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/jadicell.therapeuticsolutionsint.com\/index.php\/wp-json\/wp\/v2\/comments?post=326"}],"version-history":[{"count":12,"href":"https:\/\/jadicell.therapeuticsolutionsint.com\/index.php\/wp-json\/wp\/v2\/pages\/326\/revisions"}],"predecessor-version":[{"id":384,"href":"https:\/\/jadicell.therapeuticsolutionsint.com\/index.php\/wp-json\/wp\/v2\/pages\/326\/revisions\/384"}],"wp:attachment":[{"href":"https:\/\/jadicell.therapeuticsolutionsint.com\/index.php\/wp-json\/wp\/v2\/media?parent=326"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}